Skip to main content
. Author manuscript; available in PMC: 2018 May 21.
Published in final edited form as: Semin Neurol. 2017 May 16;37(2):215–227. doi: 10.1055/s-0037-1602422

Table 3.

PSP Syndromes

Variant PSP Clinical Features Regional Pathology*
PSP-RS (Richardson Syndrome) Early gait instability, falls, supranuclear gaze palsy, axial rigidity, dysarthria, dysphagia, progressive dementia Dentate, globus pallidus, striatum, midbrain, and superior cerebellar (CBL) peduncle
PSP-Parkinsonism Tremor, rigid-bradykinesia, Levodopa responsive**
Late cognitive decline
Longer life expectancy (9+ yrs)
Substantia nigra, subthalamic nucleus
PSP-PAGF (Pure akinesia-gait failure) Early gait difficulty, freezing of gait/motor block, micrographia, speech impairment, hypophonia
Disease duration (11–15 yr)
Motor cortex, pons, cerebellum
PSP-CBS Dystonia, dyspraxia, cortical sensory loss, apraxia speech Frontal and parietal cortex
PSP-bvFTD (behavioral variant FTD) Predominant cognitive, personality change, late Parkinsonism Frontotemporal cortex
PSP-PLS (primary lateral sclerosis) Bulbar, limb weakness, upper motor neuron signs/spasticity Frontal predominant, corticospinal tract
PSP-cerebellar Cerebellar ataxia Deep cerebellar nuclei
*

Levodopa response for PSP-Parkinsonism diminishes later in disease.

(Reprinted with permission from McFarland NR. Diagnostic Approach to Atypical Parkinsonian Syndromes. Continuum 2016;22(4):1123. doi: 10.1212/CON.0000000000000348)